Kidney Cancer | Tumor

Early Study Shows Potential Use of Investigational Drug in Patients With Kidney, Lung Cancer

October 5th 2019

The tumors of patients with non-small cell lung and renal cell cancer shrunk following treatment with pegilodecakin plus immunotherapy.

Cancer Survivorship Encouragement

September 30th 2019

Friday Frontline: Cancer Updates, Research and Education on September 13, 2019

September 13th 2019

From a Hallmark Channel actor revealing a kidney cancer diagnosis to a donor match first-time meeting 20 years later, here’s what is making headlines in the cancer space this week.

Targeted Therapies May Benefit Older Patients With Metastatic Renal Cell Carcinoma

July 12th 2019

Patients with renal cell carcinoma who were treated with a targeted therapy lived three months longer than people who received older treatments.

Future of Renal Cell Carcinoma: Hope Is on the Horizon

July 10th 2019

One expert discusses the “extremely interesting and extremely dynamic” field of renal cell carcinoma, and how recent research and FDA actions could offer hope for patients and their doctors.

Collection of Family Cancer History Is Suboptimal, Highlighting Need for Patient Reporting

June 24th 2019

In assessing the quality of family cancer history entered into electronic health records, researchers found that such reporting was suboptimal – highlighting the need to optimize online collection with a provider-free approach.

The Typical Prognosis of Aggressive Renal Cell Cancer

June 24th 2019

The Impact of Support Networks & Multidisciplinary Care

June 24th 2019

Cabozantinib Dose Modification

June 24th 2019

Undergoing Treatment: Cabozantinib Toxicity Management

June 24th 2019

Frontline Treatment Options for Stage 4 RCC

June 24th 2019

Advice for Patients with RCC Choosing a Treatment Option

June 24th 2019

The Diagnosis of a Patient with Stage 4 Renal Cell Cancer

June 24th 2019

Despite Advantages, Disparities in Access to Palliative Care in Kidney Cancer Remain

June 19th 2019

Although palliative care has been shown to improve survival rates among patients with metastatic renal cell carcinoma, its utilization remains low while certain barriers and disparities still exist.

Novel 'Theranostic' Screening Tool Shows Promise in Determining Kidney Cancer Treatment

June 17th 2019

A novel imaging test developed at UT Southwestern may help to determine which patients with kidney cancer would benefit from treatment with immunotherapy.

Survey Results Highlight Unmet Needs of Patients with Kidney Cancer Worldwide

June 13th 2019

An international study of nearly 2,000 patients with renal cell carcinoma exposed many unmet needs across all stages of disease.

Immunotherapy Combinations Transform Renal Cell Carcinoma Treatment

May 22nd 2019

Patients with advanced renal cell carcinoma have new first-line therapy options.

FDA Approves Bavencio-Inlyta Combo for Advanced Renal Cell Carcinoma

May 15th 2019

The Food and Drug Administration approved the combination use of Bavencio plus Inlyta for the first-line treatment of patients with advanced renal cell carcinoma.

Yervoy Plus Opdivo Appears to be a Cost-Effective Treatment Option in Kidney Cancer

May 10th 2019

With the growing price of cancer treatment, researchers evaluated the cost-effectiveness of the new standard-of-care in frontline metastatic renal cell carcinoma.

Findings Confirm Exercise Benefit for Kidney Cancer Survivors

May 9th 2019

Kidney cancer survivors who follow recommendations for physical activity experience improved quality of life, but few individuals adhere to the guidelines, according to recent findings.

Immunotherapy Combinations Show Promise in Frontline Setting for Advanced Kidney Cancer

April 29th 2019

With patient resistance to single-agent immunotherapies in the treatment of advanced renal cell carcinoma, new combination therapies are needed in the frontline setting.

The Role of Mental Health in Cancer Outcomes

April 24th 2019

A person’s pre-existing mental state may negatively influence their health, but professional support can help maintain the best mindset, say researchers.

FDA Approves Keytruda in Combination with Inlyta for Frontline Renal Cell Carcinoma

April 22nd 2019

The Food and Drug Administration approved Keytruda in combination with Inlyta for the frontline treatment of patients with advanced renal cell carcinoma.

Keytruda Combo Improves Survival in Advanced Renal Cell Carcinoma

April 19th 2019

The combination use of Keytruda plus Inlyta significantly improved survival outcomes among patients with previously untreated advanced renal cell carcinoma – the most common type of kidney cancer.

Expert Discusses Molecular Diagnosis of Renal Cell Carcinoma

March 25th 2019

There is still work to do in the field of molecular diagnosis for renal cell carcinoma, according to David I. Quinn, MBBS, Ph.D., FRACP, FACP.

Thanks to Immunotherapies, the Outlook for Patients with RCC is Changing

March 25th 2019

An expert discusses the evolving treatments for renal cell carcinoma (RCC) over the last decade, as well as the future role of immunotherapies for patients with RCC.

Kidney Cancer: Know the Risk Factors

March 11th 2019

In conjunction with Kidney Cancer Awareness Month, learn more about risk factors and treatment options for the disease.

How One Survivor 'Keeps On Keeping On'

March 7th 2019

In this week’s episode, we spoke with a patient advocate and survivor of renal cell carcinoma to help raise awareness during Kidney Cancer Awareness month.

Bavencio-Inlyta Combination Shows Promise Across Subtypes of Renal Cell Carcinoma

March 6th 2019

Frontline use of Bavencio (avelumab) plus Inlyta (axitinib) significantly improved progression-free survival compared with the standard of care in patients with advanced renal cell carcinoma.

Rising Cancer Incidence Trends in Millennials Partially Attributed to Climbing Obesity Rates

February 25th 2019

CURE® spoke with a researcher from the American Cancer Society to examine temporal trends of obesity-related cancers in younger adults.